NCT05500690View on ClinicalTrials.gov

Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

December 4, 2024

Study Completion Date

November 30, 2025

Conditions

Pregnancy; Spina Bifida, FetalEnvironmental Exposure

Interventions

DIETARY_SUPPLEMENT

Folic Acid Tablet

5 mg folic acid supplement

Trial Locations (1)

1207

National Institute of Neurosciences and Hospital, Dhaka

All Listed Sponsors

collaborator

National Institute of Neurosciences and Hospital, Dhaka

OTHER_GOV

lead

Boston Children's Hospital

OTHER

NCT05500690 - Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies | Biotech Hunter | Biotech Hunter